Royal Bank Of Canada Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN) had its target price dropped by investment analysts at Royal Bank Of Canada from $55.00 to $52.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price target indicates a potential upside of 18.39% from the company’s previous close.

A number of other equities analysts also recently commented on the stock. Wells Fargo & Company cut their target price on shares of Ryan Specialty from $43.00 to $41.00 and set an “equal weight” rating on the stock in a research note on Monday, October 12th. Cantor Fitzgerald raised their price target on shares of Ryan Specialty from $34.00 to $41.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Keefe, Bruyette & Woods increased their price objective on shares of Ryan Specialty from $48.00 to $54.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Weiss Ratings upgraded shares of Ryan Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, September 18th. Finally, Morgan Stanley lifted their target price on Ryan Specialty from $48.00 to $50.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $52.03.

Ryan Specialty Price Performance

RYAN stock traded up $0.64 on Friday, reaching $43.92. 1,609,984 shares of the company’s stock were exchanged, compared to its average volume of 2,192,033. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 3.51. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.94. The stock has a fifty day moving average of $40.41 and a 200-day moving average of $39.20. The firm has a market cap of $11.24 billion, a PE ratio of 61.19, a P/E/G ratio of 0.87 and a beta of 0.61.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Thursday, October 29th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.02. Ryan Specialty had a return on equity of 43.97% and a net margin of 7.55%. The firm had revenue of $789.96 million during the quarter, compared to analysts’ expectations of $792.99 million. During the same period in the previous year, the firm posted $0.47 earnings per share. As a group, equities analysts predict that Ryan Specialty will post 2.17 EPS for the current fiscal year.

Institutional Trading of Ryan Specialty

A number of hedge funds have recently bought and sold shares of the stock. Integrity Alliance LLC. acquired a new stake in Ryan Specialty during the third quarter worth $1,040,000. Gerber Kawasaki Wealth & Investment Management acquired a new stake in Ryan Specialty in the third quarter worth about $854,000. Vise Technologies Inc. lifted its stake in shares of Ryan Specialty by 189.0% in the 3rd quarter. Vise Technologies Inc. now owns 24,941 shares of the company’s stock valued at $923,000 after purchasing an additional 16,311 shares during the period. Motley Fool Asset Management LLC bought a new stake in Ryan Specialty in the third quarter valued at approximately $3,952,000. Finally, Compass Ion Advisors LLC bought a new stake in shares of Ryan Specialty in the 3rd quarter valued at $297,000. 84.82% of the stock is owned by institutional investors.

Trending Headlines about Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Adjusted earnings beat expectations: Third-quarter EPS was $0.51, above the $0.49 consensus and up from $0.47 a year earlier. Revenue rose 4.7% to approximately $790 million, while net income increased 40.6% to $88 million. Ryan Specialty Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Capital returned to shareholders: Ryan Specialty repurchased $150 million of stock and paid $23.7 million in dividends and distributions during the quarter. It also declared a quarterly dividend of $0.13 per share, equivalent to $0.52 annually and a yield of approximately 1.2%. Ryan Specialty Stock Rated Hold
• Positive Sentiment: New growth initiative: The company launched Tera Underwriters with $625 million of capacity, potentially expanding its specialty insurance platform and future revenue opportunities. Ryan Specialty Launches Tera Underwriters
• Neutral Sentiment: Full-year revenue outlook maintained: Management reaffirmed guidance for mid-single-digit organic revenue growth in 2026, suggesting business trends remain broadly on plan. Ryan Specialty Reports Third-Quarter Results
• Negative Sentiment: Growth and margins are under pressure: Organic growth slowed to 4% in the quarter, and management indicated that the 2026 adjusted EBITDAC margin could decline by roughly 50 basis points from the prior year. Revenue also fell slightly short of analyst estimates. Ryan Specialty Organic Growth Slows
• Negative Sentiment: Analyst stance remains cautious: Wall Street analysts currently rate Ryan Specialty “Hold,” which may limit upside given the stock’s elevated valuation and substantial leverage. Analyst Hold Rating

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.